Abstract
Currently, various heart conditions, such as hyperlipidaemia, are causing fear among people worldwide. In this research, silver nanoparticles (AgNPs) were produced using Emblica Officinallis leaf extract (EOLE). The synthesis of EOLEAgNPs was examined using UV-visible spectrophotometry at 430 nm, while the shape was determined through SEM analysis. The EDX detected a clear peak of silver (Ag) at 3.4 keV, whereas XRD exhibited a peak distribution at 2 θ° values. The TEM demonstrated a protective layer (100 nm) surrounding EOLEAgNPs. The FTIR (400-4000 cm−1) suggests the phyto-compounds that caused the reduction of AgNO3 to Ag0 ions. The EOLEAgNPs showed a lower value (IC50 = 0.12) and greater antioxidant effects compared to EOLE (IC50 = 4.9). In fact, we discovered that the HMG-CoA reductase enzyme activity of EOLEAgNPs (75.38 ± 0.06) was greater than that of EOLE (37.36 ± 0.03). E. officinallis have a high level of polyphenolics as detected by GCMS-MS. Our research results in the inhibition of HMG-CoA reductase enzyme by EOLEAgNPs, which can effectively treat hyperlipidaemia and promote the development of lipid-lowering biomedicines.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
